It is a trading private limited company based in Lalacheruvu, Andhra Pradesh, India, established in 2021.
2021 | Lalacheruvu, Andhra Pradesh, India | ActiveRusset Therapeutics Private Limited, a active private limited company, was established on 04 September 2021 in Lalacheruvu, Andhra Pradesh, India. Engaging in specialty within the trading sector, it holds CIN: U51909AP2021PTC119335. Registered under ROC Roc Vijayawada. it is unlisted. It has an authorized capital of ₹4.90 M and a paid-up capital of ₹4.90 M.
It upholds a compliant status. Employing 23 professional, Its leadership includes Venkata Nageswara Rao Thoram (Director), Sri Ravi Chandra Naga Radha Gopal Soorabathula (Managing Director), Venkata Nagalakshmi Akula (Director). Past directors included Satyanarayana Murthy Akula. Its latest AGM occurred on 24 September 2024, with the balance sheet filed on 31 March 2024. It is based at Aphb Lig 396 Palacherla Village, Lalacheruvu, Andhra Pradesh, 533106.
U51909AP2021PTC119335
119335
04 September 2021
₹4.90 M
₹4.90 M
Roc Vijayawada
Unlisted
Active
Explore comprehensive insights into Russet Therapeutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Venkata Nageswara Rao Thoram | Director | 04 Sep 2021 | Current |
| Sri Ravi Chandra Naga Radha Gopal Soorabathula | Managing Director | 04 Sep 2021 | Current |
| Venkata Nagalakshmi Akula | Director | 28 Feb 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 12 Feb 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Russet Therapeutics's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Russet Therapeutics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Russet Therapeutics has a workforce of 23 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Russet Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Russet Therapeutics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Russet Therapeutics Private Limited last Annual general meeting of members was held on 24 Sep 2024 as per latest MCA records. was recorded as a recent event.
Russet Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Vijayawada. was recorded as a recent event.
The activity Venkata Nagalakshmi Akula was appointed as a Director was appointed as a Director on 28 Feb 2024 & has been associated with this company since 1 year 9 months . was completed.
Venkata Nageswara Rao Thoram was appointed as a Director was appointed as a Director on 04 Sep 2021 & has been associated with this company since 4 years 3 months . was recorded as a recent event.
Progress on Sri Ravi Chandra Naga Radha Gopal Soorabathula was appointed as a Managing Director was appointed as a Managing Director on 04 Sep 2021 & has been associated with this company since 4 years 3 months . was documented.
The activity Russet Therapeutics Private Limited was registered on 04 Sep 2021 with Roc Vijayawada & aged 4 years 3 months as per MCA records. was completed.
The CIN of Russet Therapeutics Private Limited is U51909AP2021PTC119335.
Russet Therapeutics Private Limited is headquartered at Aphb Lig 396 Palacherla Village, Lalacheruvu, Andhra Pradesh, 533106.
Russet Therapeutics Private Limited was incorporated on 04 September 2021.
The current directors of Russet Therapeutics Private Limited are
The primary industry of Russet Therapeutics Private Limited is Trading.
Russet Therapeutics Private Limited is unlisted.
The authorized capital of Russet Therapeutics Private Limited is ₹4.90 M, and the paid-up capital is ₹4.90 M.
The compliance status of Russet Therapeutics Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX